Free Trial
NYSE:WST

West Pharmaceutical Services Q2 2025 Earnings Report

West Pharmaceutical Services logo
$210.91 -10.68 (-4.82%)
Closing price 03:59 PM Eastern
Extended Trading
$210.44 -0.47 (-0.22%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services EPS Results

Actual EPS
N/A
Consensus EPS
$1.51
Beat/Miss
N/A
One Year Ago EPS
N/A

West Pharmaceutical Services Revenue Results

Actual Revenue
N/A
Expected Revenue
$725.11 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

West Pharmaceutical Services Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, July 24, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

West Pharmaceutical Services Earnings Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
See More West Pharmaceutical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like West Pharmaceutical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your email.

About West Pharmaceutical Services

West Pharmaceutical Services (NYSE:WST) (NYSE: WST) is a global manufacturer and supplier of innovative packaging and delivery systems for injectable drugs and healthcare products. The company designs, engineers and produces a broad range of components, including elastomeric closures, syringe plungers and containment solutions that ensure drug integrity throughout development, packaging and administration. By integrating precision polymer and rubber technologies, West enables pharmaceutical and biotechnology customers to deliver safe and effective therapies to patients worldwide.

The company’s product portfolio spans co-molded elastomer components, prefillable syringes, safety systems and specialty containment platforms. West offers end-to-end support services, from concept and design through to commercial tooling and global supply chain management. Its proprietary SmartDose® wearable injector and Flip-Off® seals are widely used in subcutaneous drug delivery, while the Daikyo Crystal Zenith® polymer containers provide high-chemical resistance and reduced risk of leachables.

Founded in 1923 and headquartered in Exton, Pennsylvania, West has grown through strategic acquisitions and organic investments to establish a strong global footprint. Manufacturing and technical centers are located across North America, Europe and the Asia-Pacific region, including sites in Puerto Rico, Ireland, Germany, China and Singapore. The company maintains rigorous quality standards and regulatory compliance, supporting both large pharmaceutical firms and emerging biotech innovators.

Under the leadership of President and Chief Executive Officer Cristian J. Goodman, West continues to emphasize research and development, operational excellence and sustainability. The executive team focuses on advancing drug delivery science and expanding the company’s capacity to address evolving patient needs. Through partnerships and ongoing product innovation, West Pharmaceutical Services remains at the forefront of injectable drug packaging and delivery solutions.

View West Pharmaceutical Services Profile

More Earnings Resources from MarketBeat